Information Links
Products in Musculoskeletal Disorders > Rheumatoid arthritis, other autoimmune disorders
Anti-inflammatories
B-cell depleting agents
- Benlysta (Belimumab)
- MabThera (Rituximab)
- Rixathon (Rituximab)
- Ruxience (Rituximab)
- Truxima (Rituximab)
Complement inhibitors
- Tavneos (Avacopan)
Disease modifying antirheumatic drugs
- Arava (Leflunomide)
- Avloclor (Chloroquine)
- Azathioprine
- Capimune (Ciclosporin)
- Capsorin (Ciclosporin)
- Deximune (Ciclosporin)
- Hydroxychloroquine
- Imuran (Azathioprine)
- Jylamvo (Methotrexate)
- Leflunomide
- Methofill (Methotrexate)
- Methotrexate
- Methotrexate Oral Solution
- Metoject (Methotrexate)
- Neoral (Ciclosporin)
- Neoral Capsules (Ciclosporin)
- Nordimet (Methotrexate)
- Penicillamine
- Salazopyrin En-Tabs (Sulfasalazine)
- Sulfasalazine
- Vanquoral (Ciclosporin)
- Zlatal (Methotrexate)
Interleukin inhibitors
- Bimzelx (Bimekizumab)
- Cosentyx (Secukinumab)
- Ilaris (Canakinumab)
- Kevzara (Sarilumab)
- Kineret (Anakinra)
- Nucala (Mepolizumab)
- RoActemra (Tocilizumab)
- Skyrizi (Risankizumab)
- Stelara (Ustekinumab)
- Taltz (Ixekizumab)
- Tremfya (Guselkumab)
JAK inhibitors
- Jyseleca (Filgotinib)
- Olumiant (Baricitinib)
- Rinvoq (Upadacitinib)
- Xeljanz (Tofacitinib)
- Xeljanz Oral Solution (Tofacitinib)
- Xeljanz Prolonged-Release Tablets (Tofacitinib)
PDE4 inhibitors
- Otezla (Apremilast)
T-cell activation inhibitors
- Orencia (Abatacept)
TNF inhibitors
- Amgevita (Adalimumab)
- Benepali (Etanercept)
- Cimzia (Certolizumab pegol)
- Enbrel (Etanercept)
- Erelzi (Etanercept)
- Flixabi (Infliximab)
- Humira (Adalimumab)
- Hyrimoz (Adalimumab)
- Idacio (Adalimumab)
- Imraldi (Adalimumab)
- Inflectra (Infliximab)
- Remicade (Infliximab)
- Remsima (Infliximab)
- Remsima SC (Infliximab)
- Simponi (Golimumab)
- Yuflyma (Adalimumab)
- Zessly (Infliximab)